The microbiome–gut–brain axis in Parkinson disease—from basic research to the clinic

AH Tan, SY Lim, AE Lang - Nature Reviews Neurology, 2022 - nature.com
Evidence for a close bidirectional link between the brain and the gut has led to a paradigm
shift in neurology, especially in the case of Parkinson disease (PD), in which gastrointestinal …

New evidence on the management of Lewy body dementia

JP Taylor, IG McKeith, DJ Burn, BF Boeve… - The Lancet …, 2020 - thelancet.com
Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body
dementia, are common neurodegenerative conditions. Patients with Lewy body dementia …

Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment

S Prange, H Klinger, C Laurencin, T Danaila… - Drugs & aging, 2022 - Springer
Depression is one of the most frequent and burdensome non-motor symptoms in
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …

Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease

E De Pablo-Fernández, AJ Lees, JL Holton… - JAMA …, 2019 - jamanetwork.com
Importance Clinical subty** of Parkinson disease at diagnosis is useful in estimating
disease course and survival. Severity and rate of progression of neuropathologies are …

Evidence for early and regular physical therapy and exercise in Parkinson's disease

TD Ellis, C Colón-Semenza, TR DeAngelis… - Seminars in …, 2021 - thieme-connect.com
Advances in medical management of Parkinson's disease (PD) have resulted in living
longer with disability. Although disability worsens over the course of the disease, there are …

[PDF][PDF] Doença de Parkinson: Revisão clínica e atualização [Parkinson's disease: Clinical review and update]

V Cabreira, J Massano - Acta Med Port, 2019 - academia.edu
RESUMO A doença de Parkinson é a segunda doença neurodegenerativa mais comum,
tendo sido documentado um aumento significativo da sua prevalência nas últimas três …

Sleep and circadian rhythms in Parkinson's disease and preclinical models

J Hunt, EJ Coulson, R Rajnarayanan, H Oster… - Molecular …, 2022 - Springer
The use of animals as models of human physiology is, and has been for many years, an
indispensable tool for understanding the mechanisms of human disease. In Parkinson's …

Early predictors of mortality in parkinsonism and Parkinson disease: a population-based study

D Bäckström, G Granåsen, ME Domellöf, J Linder… - Neurology, 2018 - neurology.org
Objective To examine mortality and associated risk factors, including possible effects of mild
cognitive impairment, imaging, and CSF abnormalities, in a community-based population …

Parkinson's disease outside the brain: targeting the autonomic nervous system

Y Sharabi, GD Vatine, A Ashkenazi - The Lancet Neurology, 2021 - thelancet.com
Patients with Parkinson's disease present with signs and symptoms of dysregulation of the
peripheral autonomic nervous system that can even precede motor deficits. This …

Translational molecular imaging and drug development in Parkinson's disease

A Haider, NH Elghazawy, A Dawoud… - Molecular …, 2023 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects
elderly people and constitutes a major source of disability worldwide. Notably, the …